FGF21 and obesity due to melanocortin 4 receptor deficiency: FGF21 is generally believed to decrease blood pressure through its dramatic improvements in lipid profiles as accumulating evidence suggests that obesity and dyslipidemia are key risk factors in the development of hypertension [31–33].